Glenmark Recalls Over 110000 Bottles of BP and COPD Drugs in US Due to Safety Concerns
Glenmark Pharmaceuticals has announced a voluntary recall in the US, pulling more than 88,000 bottles of Carvedilol (a high blood pressure drug) and 22,656 bottles of Theophylline (used for COPD) from the market. The affected products were manufactured at Glenmark’s Goa and Pithampur plants in India.
The US FDA flagged five Carvedilol lots after detecting N-Nitroso Carvedilol Impurity-1 (NNCI) levels above the permissible 4.0 ppm limit, and one Theophylline lot due to failure in dissolution tests. Both issues prompted Class II recalls, suggesting the risk of serious harm is remote but temporary or reversible side effects are possible.
Carvedilol is a beta-blocker for treating hypertension, while Theophylline helps manage asthma and COPD by relaxing airway muscles. Glenmark initiated the recalls earlier this month, emphasizing patient safety and regulatory compliance.
You May Interested In
High Quality β-Nicotinamide adenine dinucleotide CAS 53-84-9 NADwith ready stock and best price
$3E+1/UNIT FOB
2026-10-25
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
The Last 10% Tariff Trap: A New Chapter in U.S.–China Negotiations on “Fentanyl Tariffs”
-
Vietnam Drives ASEAN Towards a Modern Economy
-
USDA Puts Fresh Money Into Local Food Markets
-
Redwall Raises Prices by as Much as 80%, Songwon Launches Global Increases, and Chemical Companies Are Collectively Passing On Costs
-
U.S. Strikes Three Iranian Tankers as “Tanker-for-Tanker” Escalation Raises Chemical Shipping Risk
-
"No available slots" returns as global shipping rates skyrocket amid multiple factors
-
Panama Canal Delays Deeper Draft Cut, but Transit Capacity Is Still Tightening
-
Middle East Conflict Pushes Up Oil Prices as More Than 100 Chemical Raw Materials Rise in Concentration
-
Crude Tanker Freight From the Americas to Asia Tops $80 Million per Voyage Amid Global Shipping Crunch
-
China, U.S. and Australia Escalate Antidumping Scrutiny: Chemical Exports Face Rising Compliance Pressure
Recommend Reading
-
![Iran's Only MDI/TDI Plant Attacked, Middle East Supply Nearly Zero, Global Gap Widens]()
Iran's Only MDI/TDI Plant Attacked, Middle East Supply Nearly Zero, Global Gap Widens
-
![Shandong’s Export Growth Is 2.8%; This Category Is 19%: Shandong Has a Chokehold on the Upstream of Global Manufacturing]()
Shandong’s Export Growth Is 2.8%; This Category Is 19%: Shandong Has a Chokehold on the Upstream of Global Manufacturing
-
![Keshun Enters Industrial Coatings: Waterproofing Leader Seeks Growth Beyond Real Estate]()
Keshun Enters Industrial Coatings: Waterproofing Leader Seeks Growth Beyond Real Estate
-
![Why Did Chemical Raw Materials Unexpectedly Escape the Latest Round of U.S. 301 Tariffs on 60 Economies?]()
Why Did Chemical Raw Materials Unexpectedly Escape the Latest Round of U.S. 301 Tariffs on 60 Economies?
-
![Uzbekistan Bets $17 Billion on Chemical Industry Upgrade]()
Uzbekistan Bets $17 Billion on Chemical Industry Upgrade
-
![Business Society Styrene Daily Review: August 7, 2026—Fluctuating with a Slight Tendency to Strengthen]()
Business Society Styrene Daily Review: August 7, 2026—Fluctuating with a Slight Tendency to Strengthen
-
![Business Society’s Trend Analysis for Propylene Oxide on September 18, 2026: Volatile Fluctuations]()
Business Society’s Trend Analysis for Propylene Oxide on September 18, 2026: Volatile Fluctuations
-
![Supply Boosts Consumption, But Demand Contracts—PC Prices Drop in Early June]()
Supply Boosts Consumption, But Demand Contracts—PC Prices Drop in Early June
-
![Business Society Butadiene Daily Review: Fluctuating Within a Range on August 6, 2026]()
Business Society Butadiene Daily Review: Fluctuating Within a Range on August 6, 2026
-
![Phosphate Market Prices Decline Since September (Sep 1–Sep 18)]()
Phosphate Market Prices Decline Since September (Sep 1–Sep 18)
